Does ADO-TRASTUZUMAB EMTANSINE Cause Neuropathy peripheral? 506 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 506 reports of Neuropathy peripheral have been filed in association with ADO-TRASTUZUMAB EMTANSINE. This represents 5.8% of all adverse event reports for ADO-TRASTUZUMAB EMTANSINE.
506
Reports of Neuropathy peripheral with ADO-TRASTUZUMAB EMTANSINE
5.8%
of all ADO-TRASTUZUMAB EMTANSINE reports
63
Deaths
142
Hospitalizations
How Dangerous Is Neuropathy peripheral From ADO-TRASTUZUMAB EMTANSINE?
Of the 506 reports, 63 (12.5%) resulted in death, 142 (28.1%) required hospitalization, and 5 (1.0%) were considered life-threatening.
Is Neuropathy peripheral Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADO-TRASTUZUMAB EMTANSINE. However, 506 reports have been filed with the FAERS database.
What Other Side Effects Does ADO-TRASTUZUMAB EMTANSINE Cause?
Nausea (780)
Fatigue (774)
Disease progression (750)
Diarrhoea (654)
Off label use (630)
Thrombocytopenia (519)
Death (509)
Headache (465)
Platelet count decreased (453)
Metastases to central nervous system (386)
What Other Drugs Cause Neuropathy peripheral?
LENALIDOMIDE (10,215)
BORTEZOMIB (4,067)
OXALIPLATIN (3,662)
DEXAMETHASONE (3,543)
PACLITAXEL (3,508)
LEVOFLOXACIN (2,619)
CIPROFLOXACIN (2,607)
FLUOROURACIL (2,605)
CYCLOPHOSPHAMIDE (2,565)
POMALIDOMIDE (2,382)
Which ADO-TRASTUZUMAB EMTANSINE Alternatives Have Lower Neuropathy peripheral Risk?
ADO-TRASTUZUMAB EMTANSINE vs ADRIAMYCIN
ADO-TRASTUZUMAB EMTANSINE vs ADUCANUMAB
ADO-TRASTUZUMAB EMTANSINE vs ADUCANUMAB-AVWA
ADO-TRASTUZUMAB EMTANSINE vs ADVAIR
ADO-TRASTUZUMAB EMTANSINE vs ADVAIR HFA